Target intelligence / Profile preview

Cerebral artery smooth muscle cell

Molecular classification
Other (cell type), Not a single definable molecular family (encompasses a variety of proteins such as ion channels, receptors, and contractile proteins)
01

Overview

Cerebral artery smooth muscle cells (VSMCs) are specialized contractile cells encircling the walls of arteries in the brain. They regulate cerebral blood flow by contracting or relaxing in response to neural, metabolic, and myogenic stimuli, primarily through changes in intracellular calcium and membrane potential. These cells express a diverse set of ion channels (including voltage-gated calcium channels, potassium channels such as BKCa and Kv, and non-selective cation channels of the TRP family), signaling proteins, and contractile elements (such as actins and myosins). Dysfunction of cerebral artery VSMCs contributes to diseases including hypertension, stroke, and cerebrovascular disorders. However, as a cell type rather than a specific molecule, they are not a single druggable "target" [5][1][3][2][6].

Other names
Cerebral artery vascular smooth muscle cellCerebral artery VSMCArterial smooth muscle (in cerebral arteries)VSMC of cerebral arteries
02

Mechanism of action

Not applicable as a cell type; mechanisms relate to the specific molecular targets expressed by these cells (e.g., calcium channel blockade causing vasodilation).

03

Biological functions

Regulation of cerebral blood flowVasoconstriction and vasodilation (control of vessel diameter)Maintenance of blood-brain barrier integrity (indirectly, via vessel wall properties)
04

Disease associations

Cardiovascular disease (e.g., hypertension, stroke, cerebral vasospasm)Neurodegenerative disease (via blood-brain barrier dysfunction)Other (e.g., vascular dementia, migraine)
05

Safety considerations

Not applicable directly to the cell type, but targeting vascular smooth muscle ion channels can cause hypotension, cerebrovascular ischemia, or disrupt autoregulation of cerebral blood flow
06

Interacting drugs

Drugs acting on L-type calcium channels

3 more in the full profile.

07

Biomarkers

No unique molecular biomarker for the cell type per se, but smooth muscle actin (SMA) is used as a marker to identify vascular smooth muscle cells

Beyond the preview

Go deeper on Cerebral artery smooth muscle cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebral artery smooth muscle cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call